NEDD4L, which is transcriptionally repressed by DDB2, enhances TGF-β signaling in human ovarian cancer cells, ultimately inhibiting ovarian cancer cell proliferation (Zhao et al., 2015). Here, DDB2 is linked to ovarian cancer.